PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
-11.58%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$89.9M
AUM Growth
+$89.9M
(-21%)
Cap. Flow
-$9.48M
Cap. Flow
% of AUM
-10.55%
Top 10 Holdings %
Top 10 Hldgs %
32.28%
Holding
134
New
5
Increased
30
Reduced
47
Closed
13
Top Buys
| 1 |
BEAT
BioTelemetry, Inc.
BEAT
|
$1.14M |
| 2 |
ETRM
EnteroMedics Inc.
ETRM
|
$972K |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$758K |
| 4 |
AT&T
T
|
$598K |
| 5 |
BCS.PRA.CL
Barclays Bank Plc Series 3
BCS.PRA.CL
|
$486K |
Top Sells
| 1 |
HILL
DOT HILL SYSTEMS CORP
HILL
|
$3.65M |
| 2 |
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
|
$3M |
| 3 |
Apple
AAPL
|
$1.41M |
| 4 |
Medtronic
MDT
|
$1.11M |
| 5 |
Johnson & Johnson
JNJ
|
$839K |
Sector Composition
| 1 | Healthcare | 53.07% |
| 2 | Technology | 11.65% |
| 3 | Industrials | 10.65% |
| 4 | Consumer Discretionary | 3.35% |
| 5 | Financials | 2.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
1
DELISTED
St Jude Medical
STJ
| $6.02M | 6.69% | 95,338 +1,050 | +1% | +$66.2K |
|
2
NeoGenomics
NEO
$1.13B
| $4.55M | 5.06% | 794,012 -2,918 | -0.4% | -$16.7K |
|
3
Rockwell Medical
RMTI
$58.9M
| $3.76M | 4.19% | 488,050 +4,200 | +0.9% | +$32.4K |
|
4
Axogen
AXGN
$743M
| $2.73M | 3.04% | 662,700 +29,450 | +5% | +$121K |
|
|
CSII
5
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.31M | 2.57% | 145,850 +47,850 | +49% | +$758K |
|
6
LeMaitre Vascular
LMAT
$2.16B
| $2.06M | 2.29% | 168,695 -12,110 | -7% | -$148K |
|
7
Pfizer
PFE
$141B
| $2M | 2.23% | 63,679 -250 | -0.4% | -$7.85K |
|
|
SVU
8
DELISTED
SUPERVALU Inc.
SVU
| $1.87M | 2.08% | 259,900 +5,500 | +2% | +$39.5K |
|
9
Assertio
ASRT
$80.4M
| $1.87M | 2.08% | 98,950 +500 | +0.5% | +$9.42K |
|
10
ePlus
PLUS
$1.93B
| $1.86M | 2.07% | 23,500 -1,000 | -4% | -$79.1K |
|
11
AtriCure
ATRC
$1.84B
| $1.84M | 2.05% | 84,000 | – | – |
|
12
Deluxe
DLX
$882M
| $1.74M | 1.94% | 31,208 | – | – |
|
13
Eli Lilly
LLY
$657B
| $1.7M | 1.89% | 20,300 +100 | +0.5% | +$8.37K |
|
14
Altimmune
ALT
$338M
| $1.62M | 1.8% | 1,215,600 +2,300 | +0.2% | +$3.06K |
|
15
UnitedHealth
UNH
$281B
| $1.55M | 1.72% | 13,350 | – | – |
|
|
CGNT
16
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.54M | 1.72% | 1,244,597 +193,210 | +18% | +$240K |
|
|
JCP
17
DELISTED
J.C. Penney Company, Inc.
JCP
| $1.41M | 1.57% | 151,400 +4,000 | +3% | +$37.2K |
|
18
CVS Health
CVS
$92.8B
| $1.37M | 1.52% | 14,183 | – | – |
|
|
ZIXI
19
DELISTED
Zix Corporation
ZIXI
| $1.32M | 1.47% | 314,289 -2,700 | -0.9% | -$11.4K |
|
20
SPS Commerce
SPSC
$4.18B
| $1.2M | 1.33% | 17,650 +1,600 | +10% | +$109K |
|
|
HDS
21
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.15M | 1.28% | 40,150 -1,800 | -4% | -$51.5K |
|
|
BEAT
22
DELISTED
BioTelemetry, Inc.
BEAT
| $1.14M | 1.27% | +93,450 | New | +$1.14M |
|
23
Global Payments
GPN
$21.5B
| $1.11M | 1.24% | 9,700 | – | – |
|
|
CASC
24
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.07M | 1.19% | 390,650 -13,763 | -3% | -$37.7K |
|
25
Idexx Laboratories
IDXX
$51.8B
| $1.04M | 1.16% | 14,000 | – | – |
|